All News about Beigene Ltd ADR
Via GlobeNewswire
BeiGene Earnings Perspective: Return On Capital Employed
March 02, 2023
Via Benzinga
4 Analysts Have This to Say About BeiGene
January 20, 2023
Via Benzinga
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
January 20, 2023
Via Benzinga
Via GlobeNewswire
From BeiGene
Via Business Wire
From BeiGene
Via Business Wire
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023
From BeiGene, Ltd.
Via Business Wire
BeiGene Receives 10th Approval for PD-1 Inhibitor Tislelizumab in China
February 24, 2023
From BeiGene
Via Business Wire
BeiGene to Present at Cowen’s 43rd Annual Healthcare Conference
February 24, 2023
From BeiGene
Via Business Wire
Five Best And Worst Performing Healthcare Stocks In January 2023
February 05, 2023
Via Talk Markets
BeiGene to Present at Upcoming Investor Conferences
February 01, 2023
From BeiGene
Via Business Wire
Five Best And Worst Performing Healthcare Stocks In December 2022
January 22, 2023
Via Talk Markets
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.